Notice for tofersen (Biogen Australia Pty Ltd)
Active ingredients
tofersen
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
injection (intrathecal)
Indication
Treatment of amyotrophic lateral sclerosis
Therapeutic area
Musculoskeletal